🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06991985
Starting soon Observational

Analysis of Factors Associated With The Occurrence of Amniotic Fluid Entry in Patients Undergoing Caesarean Section

NCT06991985 · tracked via the Priya Life Science China tracker
Sponsor
Second Hospital of Shanxi Medical University
Phase
Observational
Started
2025-05-20
Last updated
2025-05-28

Condition(s) studied

Amniotic Fluid Embolism

Investigational drug(s) / intervention(s)

Enzyme-linked immunosorbent assay

Enzyme-linked immunosorbent assay: Serum STN and C4 levels were detected

Study summary

To compare serum STN (Neuraminic acid-N-acetylgalactose)antigen concentrations in patients undergoing cesarean section and to study the factors associated with amniotic fluid entry.Compare the serum complement C4 concentration in patients in the amniotic fluid admission group with those in the non-admission group to study whether amniotic fluid admission triggers the body's immune response.To record the patients' blood pressure, heart rate, blood oxygen, and the occurrence of related symptoms and adverse reactions at the time of admission, at the time of blood collection, at the time of discharge from the room, and at the time of the occurrence of haemodynamic changes.

Eligibility

Sex
FEMALE
Min age
20 Years
Max age
50 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Approved consent and informed consent of the patient by the Ethics Committee of the Second Hospital of Shanxi Medical University; * ASA classification of I-III; * Age 20-50 years old; * No previous history of psychiatric diseases or psychotropic drugs; Exclusion Criteria: * Suffer from diseases of the cardiorespiratory system; * Those with communication difficulties who were unable to complete the screening questionnaire;

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Second Hospital of Shanxi Medical University Taiyuan Shanxi

More Second Hospital of Shanxi Medical University trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06991985 on ClinicalTrials.gov ↗ ← All trials in China